A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients

NCT07472491 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

640

Enrollment

INDUSTRY

Sponsor class

Conditions

Known or Highly Suspected Central Nervous System (CNS) Lesion
Known or Highly Suspected Body (Excluding CNS) Lesion

Interventions

DRUG: Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL
DIAGNOSTIC_TEST: MRI Scan
DRUG: Gadobutrol

Sponsor

GE Healthcare